News

Follow-on investment in Lunaphore

Congratulations to our portfolio company Lunaphore on the successful closing of series D1!

OCCIDENT participated in this Series D1 totaling 40 million Swiss francs under the lead of Ernst-Göhner Stiftung Beteiligungen (EGSB) together with the other existing investors PHC Holdings Corporation, Swiss Entrepreneurs Fund and Redalpine.

The funds will be used to strengthen the growing product portfolio offering in spatial biology and support commercialization to meet ever-growing customer demand. We look forward to the next exciting steps in the company’s development!

More information in the press release under the followin Link.

More about Lunaphore

Hemotune launches feasibility project with AstraZeneca Overview International Women’s Day
Want to learn more about OCCIDENT?

News